Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Statistics

Total Valuation

ASX:ALA has a market cap or net worth of AUD 108.11 million. The enterprise value is 87.23 million.

Market Cap	108.11M
Enterprise Value	87.23M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:ALA has 1.20 billion shares outstanding. The number of shares has increased by 16.55% in one year.

Current Share Class	1.20B
Shares Outstanding	1.20B
Shares Change (YoY)	+16.55%
Shares Change (QoQ)	+8.14%
Owned by Insiders (%)	14.49%
Owned by Institutions (%)	15.93%
Float	906.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.43
PB Ratio	5.38
P/TBV Ratio	5.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.62
EV / Sales	25.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.88

Financial Position

The company has a current ratio of 14.18

Current Ratio	14.18
Quick Ratio	14.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.98% and return on invested capital (ROIC) is -31.54%.

Return on Equity (ROE)	-47.98%
Return on Assets (ROA)	-28.30%
Return on Invested Capital (ROIC)	-31.54%
Return on Capital Employed (ROCE)	-39.28%
Weighted Average Cost of Capital (WACC)	3.54%
Revenue Per Employee	127,411
Profits Per Employee	-278,117
Employee Count	27
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.63% in the last 52 weeks. The beta is -0.13, so ASX:ALA's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-52.63%
50-Day Moving Average	0.08
200-Day Moving Average	0.09
Relative Strength Index (RSI)	54.69
Average Volume (20 Days)	1,266,652

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ALA had revenue of AUD 3.44 million and -7.51 million in losses. Loss per share was -0.01.

Revenue	3.44M
Gross Profit	3.44M
Operating Income	-7.90M
Pretax Income	-7.51M
Net Income	-7.51M
EBITDA	-7.79M
EBIT	-7.90M
Loss Per Share	-0.01

Balance Sheet

The company has 20.88 million in cash and n/a in debt, with a net cash position of 20.88 million or 0.02 per share.

Cash & Cash Equivalents	20.88M
Total Debt	n/a
Net Cash	20.88M
Net Cash Per Share	0.02
Equity (Book Value)	20.08M
Book Value Per Share	0.02
Working Capital	19.68M

Cash Flow

In the last 12 months, operating cash flow was -6.93 million and capital expenditures -412,897, giving a free cash flow of -7.34 million.

Operating Cash Flow	-6.93M
Capital Expenditures	-412,897
Free Cash Flow	-7.34M
FCF Per Share	-0.01

Margins

Gross margin is 100.00%, with operating and profit margins of -229.61% and -218.28%.

Gross Margin	100.00%
Operating Margin	-229.61%
Pretax Margin	-218.28%
Profit Margin	-218.28%
EBITDA Margin	-226.49%
EBIT Margin	-229.61%
FCF Margin	n/a

Dividends & Yields

ASX:ALA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.55%
Shareholder Yield	-16.55%
Earnings Yield	-6.95%
FCF Yield	-6.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 14, 2019. It was a reverse split with a ratio of 0.04.

Last Split Date	Nov 14, 2019
Split Type	Reverse
Split Ratio	0.04

Scores

ASX:ALA has an Altman Z-Score of 52.97 and a Piotroski F-Score of 2.

Altman Z-Score	52.97
Piotroski F-Score	2